WG Critical Care, LLC
19 drugs in NADAC|19 Generic,0 Brand
WG Critical Care, LLC lists 19 NDCs in the CMS NADAC file (19 generic, 0 brand), at an average NADAC of $6.77 per unit, with a week-over-week move of +0.7% across products that moved. The firm's full portfolio, pricing trend are listed below.
Total Drugs
19
19G / 0B
Avg Price / Unit
$6.7653
$1.07 – $26.63
Avg 7d Change
+0.67%
Across 7 drugs with changes
7d Activity
of 19 total drugs
Portfolio Price Trend
Monthly average NADAC price across all drugs
Keep following this manufacturer
These next-step links connect the manufacturer page to the markets, classes, and trend views most likely to deepen research.
Lead market
Ceftriaxone market
See the molecule this manufacturer shows up in most often and compare it against competing suppliers.
Lead class
Cephalosporin Antibacterial therapeutic class
Review the broader class where WG Critical Care, LLC has the strongest current portfolio footprint.
Trend hub
Portfolio trend view
Jump to the trend hub to compare this manufacturer against the rest of the market on weekly price movement.
Guide
NADAC pricing primer
Use the explainer for context on the benchmark this manufacturer is being compared against.
Frequently Asked Questions
How many drugs does WG Critical Care, LLC make?
WG Critical Care, LLC lists 19 NDCs in the CMS NADAC file — 19 generic and 0 brand products.
What is the average price of WG Critical Care, LLC drugs?
The average NADAC across WG Critical Care, LLC's portfolio is $6.7653 per unit, ranging from $1.0703 to $26.6295.
What types of drugs does WG Critical Care, LLC make?
WG Critical Care, LLC makes drugs across 4 FDA pharmacologic classes. The most common by NDC count are Cephalosporin Antibacterial (11), Penem Antibacterial (5), Penicillin-class Antibacterial (3), beta Lactamase Inhibitor (2).
Has WG Critical Care, LLC had any drug recalls?
No FDA enforcement recalls are matched to WG Critical Care, LLC in the openFDA feed.
How has WG Critical Care, LLC's pricing changed recently?
Over the past 7 days, 6 WG Critical Care, LLC products rose and 1 fell, with a portfolio-wide average change of +0.7%.
| Drug ↕ | Price | 7d Change ↕ |
|---|---|---|
ERTAPENEM 1 GRAM VIAL ertapenem | $26.6295 per EA | -4.06% |
CEFTRIAXONE 10 GM VIAL Ceftriaxone | $25.2133 per EA | — |
AMPICILLIN-SULBACTAM 15 GM VL Ampicillin and Sulbactam | $24.6333 per EA | — |
CEFEPIME HCL 2 GRAM VIAL Cefepime | $5.3480 per EA | — |
CEFEPIME HCL 2 GRAM VIAL Cefepime | $5.3480 per EA | — |
MEROPENEM IV 1 GM VIAL Meropenem | $4.6875 per EA | +0.40% |
MEROPENEM IV 1 GM VIAL Meropenem | $4.6875 per EA | +0.40% |
CEFEPIME HCL 1 GM VIAL Cefepime | $3.7308 per EA | — |
CEFEPIME HCL 1 GM VIAL Cefepime | $3.7308 per EA | — |
CEFTAZIDIME 1 GM VIAL Ceftazidime | $3.7045 per EA | — |
PIPERACIL-TAZOBACT 3.375 GM VL PIPERACILLIN SODIUM,TAZOBACTAM SODIUM | $3.4926 per EA | — |
CEFTRIAXONE 500 MG VIAL Ceftriaxone | $3.3386 per EA | — |
AMPICILLIN 2 GM VIAL Ampicillin | $3.2338 per EA | — |
MEROPENEM IV 500 MG VIAL Meropenem | $2.8678 per EA | — |
MEROPENEM IV 500 MG VIAL Meropenem | $2.8678 per EA | — |
CEFTRIAXONE 1 GM VIAL Ceftriaxone | $1.4434 per EA | +0.05% |
CEFTRIAXONE 1 GM VIAL Ceftriaxone | $1.4434 per EA | +0.05% |
CEFAZOLIN 1 GM VIAL Cefazolin | $1.0703 per EA | +3.91% |
CEFAZOLIN 1 GM VIAL Cefazolin | $1.0703 per EA | +3.91% |